Podcast 10 Oct 2025Contraline’s ADAM in the clinic: towards a new era of male contraception? In this week’s podcast we talked with Kevin Eisenfrats, CEO of Contraline, about contraception, male contraception. October 10, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 7 Oct 2025 Six companies leading the mRNA revolution in biotechnology Here are six mRNA biotechs that have raised funds in recent years to push their candidates ahead through preclinical and clinical trials. October 7, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2025 First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics? FDA approval for Stealth BioTherapeutics’ elamipretide has been a long time coming. What does this mean for other ultra-rare disease companies? September 29, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Allucent 23 Sep 2025 The Netherlands: A strategic gateway for biotech clinical trials Discover why the Netherlands is a leading hub for biotech clinical trials, with unique advantages, challenges, and strong European impact. September 23, 2025 - 7 minutesmins - By Francina Agosti Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2025 GLP-1 drugs on WHO Essential Medicines List: what’s the impact? The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision. September 19, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Aug 2025 Five biotech companies in South Korea you should know about Discover five South Korean biotechs that have received funding in recent years and are broadening R&D in various therapeutics areas. August 26, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Aug 2025 Injecting hope into skin cancer treatment: The promise of melanoma vaccines Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer. August 13, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 11 Aug 2025 Zombie biotechs and the mission to make them disappear fast Zombie biotechs continue to exist despite setbacks. Some players in the industry want to free the capital and eliminate these companies. August 11, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2025 Fusion proteins attract funds and biopharma partnerships Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial success. August 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 1 Aug 2025 Oncolytic virus therapy for cancer: what’s been going on in 2025? This past year has seen various developments in the field of oncolytic virus therapies – in fundraising and in the clinic. August 1, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 30 Jul 2025 Targeting orexin: the future of narcolepsy treatments There are a few new narcolepsy treatments being tested in the clinic, and recently, some of them have made promising strides. But how far along are they? July 30, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Jul 2025 Which biotech companies are gaining traction in genetic diseases? Discover twelve companies focused on genetic diseases that managed to close funding rounds in the last two years. July 24, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email